BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4143315)

  • 1. Treatment of parkinsonism with bromocriptine.
    Calne DB; Teychenne PF; Leigh PN; Bamji AN; Greenacre JK
    Lancet; 1974 Dec; 2(7893):1355-6. PubMed ID: 4143315
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Bromocriptine in parkinsonism.
    Debono AG; Donaldson I; Marsden CD; Parkes JD
    Lancet; 1975 Nov; 2(7942):987-8. PubMed ID: 53479
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies with bromocriptine. Part 1. "On-off" phenomena.
    Kartznel R; Calne DB
    Neurology; 1976 Jun; 26(6 PT 1):508-10. PubMed ID: 945489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral lisuride in Parkinson's disease].
    Obeso JA; Luquin MR; Martínez Lage JM
    Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
    Kartzinel R; Shoulson I; Calne DB
    Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Bromocriptine in parkinsonism.
    Lees AJ; Shaw KM; Stern GM
    Lancet; 1975 Oct; 2(7937):709-10. PubMed ID: 52084
    [No Abstract]   [Full Text] [Related]  

  • 7. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Parkes JD; Debono AG; Marsden CD
    J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1101-8. PubMed ID: 1036999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
    Kartzinel R; TEYCHENNE P; Gillespie MM; Perlow M; Gielen AC; Sadowsky DA; Calne DB
    Lancet; 1976 Aug; 2(7980):272-5. PubMed ID: 59850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of parkinsonism.
    Calne DB; Teychenne PF; Pfeiffer RF
    Adv Exp Med Biol; 1977; 90():49-61. PubMed ID: 930750
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term use of dopamine agonists in Parkinson's disease.
    Jankovic J
    Clin Neuropharmacol; 1985; 8(2):131-40. PubMed ID: 3891082
    [No Abstract]   [Full Text] [Related]  

  • 11. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
    Kissel P; Andre JM; Jacquier A
    Nouv Presse Med; 1976 Jan; 5(4):210. PubMed ID: 1264671
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
    Godwin-Austen RB; Smith NJ
    J Neurol Neurosurg Psychiatry; 1977 May; 40(5):479-82. PubMed ID: 330825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisuride in the treatment of Parkinsonism.
    Schachter M; Sheehy MP; Parkes JD; Marsden CD
    Acta Neurol Scand; 1980 Dec; 62(6):382-5. PubMed ID: 7468157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of parkinsonism with bromocriptine.
    Calne DB; Plotkin C; Williams AC; Nutt JG; Neophytides A; Teychenne PF
    Lancet; 1978 Apr; 1(8067):735-8. PubMed ID: 76747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of parkinson's disease with bromocriptine.
    Lieberman A; Kupersmith M; Estey E; Goldstein M
    N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
    Meco G; Casacchia M; Zamponi A; Agnoli A
    Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
    Dufresne JJ
    Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
    [No Abstract]   [Full Text] [Related]  

  • 18. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic agonists in Parkinsonism.
    Claveria LE; Teychenne PF; Calne DB; Petrie A; Bassendine MF
    Adv Neurol; 1975; 9():383-92. PubMed ID: 1096576
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experience with bromocriptine, a central dopaminergic stimulator].
    Ludin HP; Kunz F; Lörincz P; Ringwald E
    Nervenarzt; 1976 Nov; 47(11):651-5. PubMed ID: 794749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.